Abstract
Purpose
To investigate the association between different treatments of tubal ectopic pregnancy (EP) —expectant management, methotrexate (MTX), selected or recommended laparoscopic surgery—and the subsequent reproductive outcomes.
Methods
We conducted a retrospective cohort study including 228 EPs. The patients were divided into four treatment groups: 28 (12.3%) with expectant management successfully, 60 (26.3%) with MTX successfully, 140 patients with laparoscopic salpingectomy, of which 47 (20.6%) were assigned to selected surgery group because they opted for surgical treatment versus MTX, 93 (40.8%) were assigned to recommended surgery group as recommended by the attending physician.
Results
The recommended surgery group had the lowest rate of intrauterine pregnancy (IUP) (77.42%) and live birth (LB) (72.04%), while the incidence of recurrent EP (REP) (20.43%) was the highest, but the statistical differences were not significant. We did not observe significant differences of the EP-IUP time interval, rates of LB and miscarriage (MIS) between the four groups. Compared to the MTX group, recommended surgery was negatively associated with IUP (adjusted OR, 95%CI: 0.34, 0.11–1.03) and LB (0.35, 0.14–0.92), while it had higher risk for REP (3.48, 1.03–11.74) in the subsequent pregnancy. Further, compared to selective surgery group, recommended surgery was negatively associated with IUP (0.15, 0.03–0.68) and LB (0.23, 0.07–0.74), while it had higher risk for REP (6.83, 1.43–32.67) in the subsequent pregnancy. Expectant treatment was negatively associated with assisted reproductive technology (ART) (0.08, 0.02–0.40) compared with MTX. Of the185 patients who had LBs, all adverse outcomes were not statistically different between the four groups.
Conclusion
Patients with recommended laparoscopic salpingectomy had worse reproductive outcomes than the other treatment groups. The disease status of EP may play an important role in the association rather than the surgery alone.
Similar content being viewed by others
References
Creanga AA, Syverson C, Seed KCallaghan WM. (2017) Pregnancy-related mortality in the United States 2011–2013. Obstet Gynecol 130:366–373
Wang E, Glazer KB, Howell EAJanevic TM. (2020) Social determinants of pregnancy-related mortality and morbidity in the united states: a systematic review. Obstet Gynecol 135:896–915
Bouyer J, Coste J, Fernandez H, Pouly JLJob-Spira N. (2002) Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod 17:3224–3230
Abusheikha N, Salha OBrinsden P, (2000) Extra-uterine pregnancy following assisted conception treatment. Hum Reprod Update 6:80–92
Naveed AK, Anjum MU, Hassan AMahmood SN. (2021) Methotrexate versus expectant management in ectopic pregnancy: a meta-analysis. Arch Gynecol Obstet 305(3):547–543
Korhonen J, Stenman UHYlostalo P. (1994) Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril 61:632–636
Menon S, Colins JBarnhart KT. (2007) Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review. Fertil Steril 87:481–484
Cohen A, Zakar L, Gil Y, Amer-Alshiek J, Bibi G et al (2014) Methotrexate success rates in progressing ectopic pregnancies: a reappraisal. Am J Obstet Gynecol 211(128):e1-5
Committee on Practice B-G (2018) ACOG practice bulletin no 191: tubal ectopic pregnancy. Obstet Gynecol 131:e65–e77
Zubaidi Al, AEid MM. (2021) The diagnostic utility of placental growth factor in ectopic pregnancy. Arch Gynecol Obstet 304:833–838
Park EHG, Mohammadi-Zaniani G, Pronin S, Elderfield CHJDuncan WC. (2017) Subsequent pregnancy outcome of tubal ectopic pregnancies treated by methotrexate and salpingectomy. Eur J Obstet Gynecol Reprod Biol 212:192–193
Helmy S, Sawyer E, Ofili-Yebovi D, Yazbek J, Ben Nagi J et al (2007) Fertility outcomes following expectant management of tubal ectopic pregnancy. Ultrasound Obstet Gynecol 30:988–993
Baggio S, Garzon S, Russo A, Ianniciello CQ, Santi L et al (2021) Fertility and reproductive outcome after tubal ectopic pregnancy: comparison among methotrexate, surgery and expectant management. Arch Gynecol Obstet 303:259–268
Chouinard M, Mayrand MH, Ayoub A, Healy-Profitos JAuger N. (2019) Ectopic pregnancy and outcomes of future intrauterine pregnancy. Fertil Steril 112:112–119
Bhattacharya S, Townend J, Shetty A, Campbell DBhattacharya S. (2008) Does miscarriage in an initial pregnancy lead to adverse obstetric and perinatal outcomes in the next continuing pregnancy? BJOG 115:1623–1629
Olofsson JI, Poromaa IS, Ottander U, Kjellberg LDamber MG. (2001) Clinical and pregnancy outcome following ectopic pregnancy; a prospective study comparing expectancy, surgery and systemic methotrexate treatment. Acta Obstet Gynecol Scand 80:744–749
Li J, Jiang KZhao F. (2015) Fertility outcome analysis after surgical management of tubal ectopic pregnancy: a retrospective cohort study. BMJ Open 5:e007339
Turan V (2011) Fertility outcomes subsequent to treatment of tubal ectopic pregnancy in younger Turkish women. J Pediatr Adolesc Gynecol 24:251–255
Roitman MS, Wainstock T, Sheiner E, Leibson TPariente G. (2021) Ectopic pregnancy: perinatal outcomes of future gestations and long-term neurological morbidity of the offspring. Arch Gynecol Obstet 304:633–640
Funding
This work was supported by [The National Natural Science Foundation of China] (Grant numbers [81971338] and [81971338], Wen Lu).
Author information
Authors and Affiliations
Contributions
YS Data collection, Data analysis, Manuscript writing and editing, Forming Table 1/2/3 and Fig. 1, Manuscript revision. YY Data analysis, Statistical analysis, Forming Fig. 2, Manuscript revision. PZ Data collection. LH Data collection. RC Data collection. ZL Statistical analysis, Manuscript revision. WL Project development, Manuscript revision.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
This study was approved by the Ethics Committee, Shanghai First Maternity and Infant Hospital, No. KS21336.
Consent to publications
All authors consent to the publication of this manuscript.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shen, Yt., Yang, Yy., Zhang, Pg. et al. Tubal ectopic pregnancy: a retrospective cohort study on clinical characteristics, treatment options and reproductive outcomes within 5 years. Arch Gynecol Obstet 306, 2055–2062 (2022). https://doi.org/10.1007/s00404-022-06690-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-022-06690-2